亞翔集成(603929.SH):擬以3000萬新加坡元設立新加坡全資子公司
格隆匯3月13日丨亞翔集成(603929.SH)公佈,公司擬以等值3000萬新加坡元的自有資金對外投資設立新加坡全資子公司(以下簡稱“子公司”)。公司將充分利用包括新加坡在內的東南亞地區的地理位置、貿易環境、投資環境、人才資源及芯片產業鏈的快速集聚等優勢,進一步推動海外業務的發展,提升公司整體競爭力。
本次對外投資設立新加坡全資子公司是公司實現東南亞業務佈局的重要一步。本次對外投資也能積極應對國際形勢變化,防範局部市場貿易風險,有利於增強公司抗風險能力。本次對外投資有利於提升公司整體競爭力及抗風險能力,對公司的未來發展具有積極影響,符合公司的中長期戰略規劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.